Shortcuts Reviewers 2018

open access

Vol 12, No 2 (2014)
Prace poglądowe (nadesłane)
Get Citation

Dapoxetine — new drug for treatment of premature ejaculation

Bartosz Puchalski, Filip M. Szymański
Seksuologia Polska 2014;12(2).

open access

Vol 12, No 2 (2014)
Prace poglądowe (nadesłane)

Abstract

Premature ejaculation and erectile dysfunction are one of the most common sexual dysfunction affecting men. Dapoxetine is a novel, oral selective serotonin re-uptake inhibitor which is dedicated to treat patients with premature ejaculation. It is usually recommended in dose 30−60 mg 1−3 hours before planned sexual intercourse. Dapoxetine is safe and well-tolerated drug which does not cause significant side effects.

Abstract

Premature ejaculation and erectile dysfunction are one of the most common sexual dysfunction affecting men. Dapoxetine is a novel, oral selective serotonin re-uptake inhibitor which is dedicated to treat patients with premature ejaculation. It is usually recommended in dose 30−60 mg 1−3 hours before planned sexual intercourse. Dapoxetine is safe and well-tolerated drug which does not cause significant side effects.

Get Citation

Keywords

dapoxetine, premature ejaculation,selective serotonin re-uptake inhibitors

About this article
Title

Dapoxetine — new drug for treatment of premature ejaculation

Journal

Seksuologia Polska (Polish Sexology)

Issue

Vol 12, No 2 (2014)

Bibliographic record

Seksuologia Polska 2014;12(2).

Keywords

dapoxetine
premature ejaculation
selective serotonin re-uptake inhibitors

Authors

Bartosz Puchalski
Filip M. Szymański

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Wydawcą serwisu jest  Via Medica sp. z o.o. sp. komandytowa, ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl